A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: OSA - Obstructive Sleep Apnea, Obesity
In brief
The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA but not receiving PAP
Key facts
- Study ID
- NCT07387094
- Run by
- Hangzhou Sciwind Biosciences Co., Ltd.
- People needed
- 140
- Starts
- 2026-02-09
- Expected to finish
- 2027-12-16
- Last updated by the study team
- 2026-04-14
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Body mass index (BMI) ≥ 28.0 kg/m2;
- The results of PSG meet the diagnosis criteria of OSA and with an AHI ≥15 at screening;
- Participants must not have used PAP for at least 4 weeks prior to screening and not use PAP during the study;
- Have a history of at least 1 self-reported unsuccessful dietary effort to lose body weight.
You may not qualify if…
- History of endocrine disorders which have significant impact on body weight;
- Diagnosis of diabetes (except gestational diabetes), ketoacidosis or hypertonic state/coma;
- HbA1c ≥6.5% at screening;
- Fasting blood glucose ≥7.0 mmol/L or 2-hour blood glucose ≥11.1 mmol/L after oral glucose tolerance test (OGTT) at screening; participants with FBG ≥6.1 mmol/L but <7.0 mmol/L require OGTT;
- Have diagnosis of Cheyne Stokes Respiration, or diagnosis of Central or Mixed Sleep Apnea with % of mixed or central apneas/hypopneas ≥50%;
- Respiratory and neuromuscular diseases that could interfere with the results of the trial;
- Diagnosis of Obesity Hypoventilation Syndrome or daytime hypercapnia;
- Change of body weight >5% within 3 months prior to screening (self-reported);
- Have a prior or planned surgical treatment for obesity (except liposuction or abdominoplasty if performed more than 1 year prior to screening);
- Have received any medication for body weight loss and blood glucose lowering or medication that could lead to significant body weight increase, within 3 months prior to screening.
Where it is running
- Peking University People's Hospital — Beijing, Beijing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.